Dengvaxia
Product Images NDC 49281-605

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dengvaxia (NDC 49281-605). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi Vaccines Us Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Dengvaxia 01)

An instructional diagram showing the preparation of Dengvaxia by drawing 0.6 mL of diluent from a vial into a syringe. The vial is inverted, and an arrow indicates the volume of diluent to be withdrawn.*

FDA Label Image

Figure 2 (Dengvaxia 02)

An illustration showing a syringe drawing liquid from a vial labeled 'Antigen.' This graphic likely depicts preparation steps for administering the Dengvaxia vaccine by Sanofi Vaccines US Inc.*

FDA Label Image

Figure 3 (Dengvaxia 03)

An instructional illustration depicting three vials labeled "Antigen" with syringes inserted. Arrows indicate a tilting motion of the vials, suggesting a step in vaccine preparation or mixing. The style is simple and monochrome.*

FDA Label Image

Figure 4 (Dengvaxia 04)

An instructional diagram showing a syringe drawing 0.5 mL of liquid from a vial labeled 'Antigen.' The vial is inverted above the syringe, with arrows indicating the liquid withdrawal process.*

FDA Label Image

Principal Display Panel (Kit Carton)

Dengvaxia carton label for Dengue Tetravalent Vaccine, Live by Sanofi Pasteur. Contains lyophilized vaccine antigen and saline diluent to be combined before use for ages 9 through 16 years. Includes storage, reconstitution, and administration instructions. Displays NDC 49281-605-01 and holographic security sticker area.*

FDA Label Image

Principal Display Panel (0.5 mL Vial Label)

Label for Dengvaxia, a lyophilized vaccine antigen to be reconstituted with saline diluent (0.4% NaCl). The label indicates a 0.5 mL single dose for subcutaneous use. Manufactured by Sanofi Pasteur Inc., it displays the product NDC 49281-606-58 and is designated for prescription use only.*

FDA Label Image

Principal Display Panel (0.6 mL Vial Label)

Label for Dengvaxia saline diluent, 0.6 mL single-dose. It contains 0.4% sodium chloride and is indicated not to be used alone. The diluent is to be added to one vial of lyophilized vaccine antigen to form Dengvaxia. Manufactured by Sanofi Pasteur Inc., Swiftwater, PA, USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.